All Stories

  1. Bacterial extracellular vesicles: their role in antibiotic resistance and immune evasion
  2. Cell-free nucleic acids as biomarkers of cardiovascular diseases: prospects and limitations
  3. Inflammasome — a new look at the therapy of cardiovascular diseases. Part II
  4. Electrospinning of Chitosan–Halloysite Nanotube Biohybrid Mats for Clobetasol Propionate Delivery
  5. Nitrogen-Doped Diamond-like Coatings for Long-Term Enhanced Cell Adhesion on Electrospun Poly(ε-caprolactone) Scaffold Surfaces
  6. The effect of sevoflurane and propofol on serum nuclear and mitochondrial DNA in pediatric patients with craniosynostosis
  7. Differences in Plasma Extracellular Vesicles of Different Origin in On-Pump Versus Off-Pump Cardiac Surgery
  8. T Regulatory Cell Subsets Do Not Restore for One Year After Acute COVID-19
  9. DIAGNOSTIC POTENTIAL OF DETERMINING INDIVIDUAL EXTRACELLULAR VESICLES SUBSETS IN CLINICAL PRACTICE
  10. FEATURES OF EXTRACELLULAR VESICLE PRODUCTION BY THP-1 CELLS DURING IN VITRO STIMULATION
  11. Electrospun Composites of Chitosan with Cerium Oxide Nanoparticles for Wound Healing Applications: Characterization and Biocompatibility Evaluation In Vitro and In Vivo
  12. Inflammasome - a new look at the therapy of cardiovascular diseases: a review. Part I
  13. Main circulating CD8<sup>+</sup> T cell subsets in patients with systemic lupus erythematosus
  14. Topographic Distribution of miRNAs (miR-30a, miR-223, miR-let-7a, miR-let-7f, miR-451, and miR-486) in the Plasma Extracellular Vesicles
  15. Immunological Profile and Markers of Endothelial Dysfunction in Elderly Patients with Cognitive Impairments
  16. Deep Immunophenotyping of Circulating T and B Cells in Relapsing Adult-Onset Still’s Disease
  17. Circulating CD8+ T Cell Subsets in Primary Sjögren’s Syndrome
  18. Chitosan Composites with Bacterial Cellulose Nanofibers Doped with Nanosized Cerium Oxide: Characterization and Cytocompatibility Evaluation
  19. Biocomposite films based on chitosan and cerium oxide nanoparticles with promising regenerative potential
  20. Modulation of Notch Signaling at Early Stages of Differentiation of Human Induced Pluripotent Stem Cells to Dopaminergic Neurons
  21. Nitrogen-Doped Diamond-Like Coatings for Long-Term Enhanced Cell Adhesion on Electrospun Poly (Ε-Caprolactone) Scaffolds Surfaces
  22. Bacterial Cellulose Composites with Polysaccharides Filled with Nanosized Cerium Oxide: Characterization and Cytocompatibility Assessment
  23. Hemolytic Activity, Cytotoxicity, and Antimicrobial Effects of Silver Nanoparticles Conjugated with Lincomycin or Cefazolin
  24. New aspects of the influence of immunity and microbiome on heart transplant rejection
  25. Cytokine Storm Signature in Patients with Moderate and Severe COVID-19
  26. T helper cell subsets and related target cells in acute COVID-19
  27. Biophysical Characterization and Cytocompatibility of Cellulose Cryogels Reinforced with Chitin Nanowhiskers
  28. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study
  29. Dysregulated Immune Responses in SARS-CoV-2-Infected Patients: A Comprehensive Overview
  30. Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19
  31. Organ-specific LPS-induced inflammatory gene expression in adult Zebrafish
  32. Synthesis and Characterization of Novel Succinyl Chitosan-Dexamethasone Conjugates for Potential Intravitreal Dexamethasone Delivery
  33. Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19
  34. Hemolytic Activity, Cytotoxicity, and Antimicrobial Effects of Human Albumin- and Polysorbate-80-Coated Silver Nanoparticles
  35. The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment
  36. Extracellular vesicles therapy: opportunities, mechanisms and perspectives
  37. Magnetron plasma mediated immobilization of hyaluronic acid for the development of functional double-sided biodegradable vascular graft
  38. Bacterial Cellulose (Komagataeibacter rhaeticus) Biocomposites and Their Cytocompatibility
  39. Mucoadhesive cholesterol-chitosan self-assembled particles for topical ocular delivery of dexamethasone
  40. Cytocompatibility of Bilayer Scaffolds Electrospun from Chitosan/Alginate-Chitin Nanowhiskers
  41. Heterogeneity of the nucleic acid repertoire of plasma extracellular vesicles demonstrated using high‐sensitivity fluorescence‐activated sorting
  42. Insights Image for “Dysregulation of Notch signaling in cardiac mesenchymal cells of patients with Tetralogy of Fallot”
  43. Changes in the expression of the MADD gene in experimental models of myocardial hypertrophy
  44. Dysregulation of Notch signaling in cardiac mesenchymal cells of patients with tetralogy of Fallot
  45. Granulocyte-Macrophage Colony-Stimulating Factor and CAR-T Technology for Solid Tumors in Experiment
  46. Dose-dependent mechanism of Notch action in promoting osteogenic differentiation of mesenchymal stem cells
  47. The role of muscle tissue in the pathogenesis of chronic heart failure — the potential of exposure (FORMA study)
  48. CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease
  49. CD39<sup>+</sup> EXPRESSION BY REGULATORY T CELLS IN PULMONARY SARCOIDOSIS AND LOFGREN’S SYNDROME
  50. Soluble triggering receptor expressed on myeloid cells 1 (sTREM-1) and polymorphic variants of TREM-1 in the development of multiple organ dysfunction syndrome after coronary artery bypass grafting
  51. Electrospun Bilayer Chitosan/Hyaluronan Material and Its Compatibility with Mesenchymal Stem Cells
  52. “Solvent/non-solvent” treatment as a method for non-covalent immobilization of gelatin on the surface of poly(l-lactic acid) electrospun scaffolds
  53. Application of high-sensitivity flow cytometry in combination with low-voltage scanning electron microscopy for characterization of nanosized objects during platelet concentrate storage
  54. Nitrogen-Doped Titanium Dioxide Thin Films Formation on the Surface of PLLA Electrospun Microfibers Scaffold by Reactive Magnetron Sputtering Method
  55. Flexible intramedullary nails for limb lengthening: a comprehensive comparative study of three nails types
  56. Time- and Ventricular-Specific Expression Profiles of Genes Encoding Z-Disk Proteins in Pressure Overload Model of Left Ventricular Hypertrophy
  57. Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations
  58. Modification of the Ceramic Implant Surfaces from Zirconia by the Magnetron Sputtering of Different Calcium Phosphate Targets: A Comparative Study
  59. PURINERGIC REGULATION OF BASIC PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES
  60. Comparative Study of the Physical, Topographical and Biological Properties of Electrospinning PCL, PLLA, their Blend and Copolymer Scaffolds
  61. Plasma-Modified PCL Scaffolds for Enhanced Biocompatibility in Tissue Engineering
  62. Fabrication and properties of l -arginine-doped PCL electrospun composite scaffolds
  63. A Randomised, Controlled Study of Different Glycaemic Targets during Gestational Diabetes Treatment: Effect on the Level of Adipokines in Cord Blood and ANGPTL4 Expression in Human Umbilical Vein Endothelial Cells
  64. Cellular Mechanisms of Aortic Valve Calcification
  65. Different Notch signaling in cells from calcified bicuspid and tricuspid aortic valves
  66. METHODS FOR INVESTIGATION OF EXTRACELLULAR VESICLE SUBPOPULATIONS
  67. Osteogenic potential of adipose mesenchymal stem cells is not correlated with aortic valve calcification
  68. Mechanisms of Smooth Muscle Cell Differentiation Are Distinctly Altered in Thoracic Aortic Aneurysms Associated with Bicuspid or Tricuspid Aortic Valves
  69. Osteoinductive composite coatings for flexible intramedullary nails
  70. Biological Effect of the Surface Modification of the Fibrous Poly(L-lactic acid) Scaffolds by Radio Frequency Magnetron Sputtering of Different Calcium-Phosphate Targets
  71. In vitro toxicity of FemOn, FemOn-SiO2 composite, and SiO2-FemOn core-shell magnetic nanoparticles
  72. APPROACHES TO BIOMATERIALS TESTING ACCORDING TO MODERN BIOCOMPATIBILITY PARADIGM
  73. PURINERGIC SIGNALING RECEPTORS EXPRESSION ON PERIPHERAL T-LYMPHOCYTES OF HEALTHY DONORS
  74. Intestinal Oxygenotherapy of Critical Conditions
  75. Association of TLR and TREM-1 gene polymorphisms with atherosclerosis severity in a Russian population
  76. Apoptosis-mediated endothelial toxicity but not direct calcification or functional changes in anti-calcification proteins defines pathogenic effects of calcium phosphate bions
  77. Effect of radio frequency discharge plasma on surface properties and biocompatibility of polycaprolactone matrices
  78. T Cell Response in Patients with Implanted Biological and Mechanical Prosthetic Heart Valves
  79. The formation of calcium phosphate coatings by pulse laser deposition on the surface of polymeric ferroelectric
  80. Modification of polylactic acid surface using RF plasma discharge with sputter deposition of a hydroxyapatite target for increased biocompatibility
  81. An association between single nucleotide polymorphisms within TLR and TREM-1 genes and infective endocarditis
  82. Association of TLR and TREM-1 gene polymorphisms with risk of coronary artery disease in a Russian population
  83. Surface modification of poly(l-lactide) and polycaprolactone bioresorbable polymers using RF plasma discharge with sputter deposition of a hydroxyapatite target
  84. Genetic predisposition to calcific aortic stenosis and mitral annular calcification
  85. Calcifying nanoparticles: one face of distinct entities?
  86. Proliferative and secretory activity of human umbilical endothelial cells cultivated under various hypoxia conditions
  87. Experimental Model of Rat Aorta Angioplasty with a Paclitaxel Releasing Balloon Catheter
  88. Perioperative Dynamics of TLR2, TLR4, and TREM-1 Expression in Monocyte Subpopulations in the Setting of On-Pump Coronary Artery Bypass Surgery
  89. sTREM-1 as a Prognostic Marker of Postoperative Complications in Cardiac Surgery
  90. O-09 Soluble triggering receptor expressed on myeloid cells (TREM-1) as a marker of noninfection systemic inflammatory response syndrome (SIRS)